Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03728660 · ClinicalTrials.gov registry record · NA

Design and Clinical Evaluation of a Smartphone-based Low Vision Enhancement System

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
88
Enrollment target

NCT03728660: Completed NA study, sponsored by Johns Hopkins University.

NCT03728660 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 88 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03728660, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
88 participants
Enrollment target

Study Summary

The primary objective is to compare the effectiveness and adverse side-effects of the virtual bioptic telescope and virtual projection screen in a new head-mounted video-based low vision enhancement system (LVES) with a wide field of view to currently employed specifications for head-mounted video display low vision enhancement technology. Secondary objectives are to acquire qualitative information from patients to evaluate the functioning of the system, to optimize system features and operations, and to assess the value patients place on system features, functions, and operating parameters relative to those of current technology. Investigators will conduct a comparative effectiveness study to determine if the novel vision enhancing features of LVES 2 provide low vision patients with benefits superior to those provided by existing technology.

Interventions

  • DEVICE Virtual bioptic magnification with large field of view
  • DEVICE Full field magnification with small field of view

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2019-01-29
Est. Completion 2021-02-05
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03728660

The ClinicalTrials.gov registry entry for NCT03728660 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Virtual bioptic magnification with large field of view is the first listed.

NCT03728660 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03728660 about?

NCT03728660 is a clinical study titled "Design and Clinical Evaluation of a Smartphone-based Low Vision Enhancement System". The primary objective is to compare the effectiveness and adverse side-effects of the virtual bioptic telescope and virtual projection screen in a new head-mounted video-based low vision enhancement system (LVES) with a wide field of view to currently employed specifications for head-mounted video d...

What is the current status of trial NCT03728660?

This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2019-01-29. Estimated completion is 2021-02-05.

What interventions are being tested in trial NCT03728660?

The interventions under investigation include: Virtual bioptic magnification with large field of view (DEVICE), Full field magnification with small field of view (DEVICE).

Who is sponsoring clinical trial NCT03728660?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.